Director @ The Neuroscience and Pain Research Unit at Pfizer is dedicated to developing new treatments for patients suffering from neurological and psychiatric disorders through the application of cutting-edge translational neuroscience. I am involved in a number of development efforts spanning Phase I through Phase 2a in the areas of schizophrenia, Alzheimer’s, and Parkinson’s disease. From March 2014 to Present (1 year 8 months) Cambridge, MassachusettsAssistant Professor (Adjunct) @ From October 2011 to Present (4 years 1 month) New Haven, ConnecticutAssociate Director @ I was a part of the GCDRA Clinical Rotation Program at Merck where I primarily supported the Neuroscience and Ophthalmology Franchise. This work included development efforts in the areas of psychiatric and neurological disorders, sleep disorders, and related conditions. The Rotation Program provided valuable experience in drug development including Experimental Medicine studies, Phase I development, and later stage development through Phase 3. From October 2011 to March 2014 (2 years 6 months) Upper Gwynedd, PennsylvaniaAssistant Professor of Psychiatry @ From July 2005 to September 2011 (6 years 3 months) New Haven, ConnecticutPsychiatry Resident, Neuroscience Research Track @ From July 2001 to June 2005 (4 years) New Haven, Connecticut

M.D., Medicine (MD/PhD program) @ University of Chicago - The Pritzker School of Medicine From 1991 to 2001 Ph.D., Neurobiology Ph.D. program @ University of Chicago - Neurobiology Ph.D. program From 1993 to 1999 Arthur PhD is skilled in: Clinical psychiatry,..., Experimental medicine..., Neuroscience, Drug Development, Clinical Development, Biostatistics, Clinical Pharmacology, Board Certified in..., Clinical Research, Molecular Biology, Genetics, Psychiatry, Neurology, Medical Research, Cognition, Biometrics, Informatics, Information Technology, Data Analysis, Clinical Trials, Infectious Diseases, Medicine, Pharmaceutical Industry